cDNA clones encoding the major subunit of the Duffy blood group were isolated from a human bone marrow cDNA library using a PCR-amplifled DNA anti-Duffy murine monoclonal antibody reacted with a synthetic peptide deduced from the cDNA clone. Hydropathy analysis suggested the presence of9 membrane-spanning a-helices. In bone marrow RNA blot analysis, the gpD cDNA detected.a 1.27-kb mRNA in Duffy-positive but not in Duffynegative individuals. It also identified the same size mRNA in adult kidney, adult spleen, and fetal liver; in brain, it detected a prominent 8.5-kb and a minor 2.2-kb mRNA. In Southern blot analysis, gpD cDNA identified a single gene in Duffypositive and -negative individuals. Duffy-negative individuals, therefore, have the gpD gene, but it is not expressed in bone marrow. The same or a similar gene is active in adult kidney, adult spleen, and fetal liver of Duffy-positive individuals. Whether this is true in Duffy-negative individuals remains to be demonstrated. A GenBank sequence search yielded a significant protein sequence homology to human and rabbit interleukin-8 receptors.
Fy(a+b-) and Fy(a-b+) human erythrocytes (4) . Receptors for erythrocyte invasion by these parasites, therefore, are related to the Duffy blood group system.
Using the anti-Fy6 monoclonal antibody, we have developed a procedure for purification of Duffy antigens in human erythrocytes (5) . Duffy antigens appear to be multimeric erythrocyte-membrane proteins composed of different sub-
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. units. A glycoprotein, named gpD, of 35-45 kDa is the major subunit of the protein complex and has the antigenic determinants defined by anti-Fya, anti-Fyb, and anti-Fy6 antibodies (5, 6) . The characterization, at the molecular level, of this protein will be crucial in finding its function on the erythrocyte membrane, in understanding the parasite-erythrocyte recognition process, and eventually in resolving the molecular mechanism of parasite invasion. This report describes the isolation, sequence analysis, and tissue expression of a mRNA encoding gpD. 1 1
MATERIALS AND METHODS
Partial Amino Acid Sequence Analysis of gpD Protein. The purified protein from Fy(a-b+) human erythrocytes (5) was alkylated and cleaved with cyanogen bromide (CNBr) as explained (7) . Pe-1 peptide was obtained by sequencing the nonfractionated CNBr digest using the o-phthalaldehyde blocking reagent (8) (see legend, Fig. 1B ). Pe-5 peptide was the partial sequence of the onily fragment (-4 kDa) that separated very well from the CNBr digest run on the threelayer SDS/PAGE system (9) . After the run, the peptide fragment was electroblotted onto ProBlott (Applied Biosystems) and sequenced (7) . Another aliquot was digested with pepsin (50: 1 ratio) at 37°C overnight, and the fragments were separated by reverse-phase HPLC using a Vydac C18 column. Pe-2, Pe-3, Pe-4, and Pe-6 peptides, which were the few pepsin peptides yielded by reverse-phase HPLC, were sequenced. Applied Biosystems protein/peptide sequencer, model 470 or 477, was used according to the manufacturer's recommendations.
Primer Design and PCR. The nucleotide sequence of the primers (23-mer each) was deduced from the N-terminal and C-terminal amino acid sequences of Pe-5 peptide (see legend, Fig. 1B ). Bases were chosen according to the codon preference described by Lathe (10) , and deoxyinosine (I) was incorporated at the position where degeneracy exceeded >3-fold, except toward the 3' end. Primer A (sense) was specific for residues 245-252 (see Fig. 1B ) and consisted of 12-fold degeneracy 5'-ATGAAYATHYTITGGGCITGGTT (where Y = C or T; and H = C, T, or A). Primer B (antisense) was specific for residues 261-268 (see Fig. 1B ) and consisted of 32-fold degeneracy 5'-ACIAGRAARTCIAGICCIARNAC (where R = A or G; and N = G, A, T, or C).
First-strand cDNA was synthesized from Fy(a-b+) phenotype mRNA using the preamplification kit from BRL and oligo(dT) as primer. For B   G GC? TCC CCA 00A CTG TIC CTG CTC CGG CTC TIC AGG C?C CC? GC? TTG TCC T1?   TCC AC? 0?C CGC AC? GCA TCT GAC TIC TGC AGA GAC CTS G0S C?C CCA CCC GAC CTT   CC? C?C TO? CCT CCC CTC CCA CCT 0CC CCT CAG STC CCA GoA GAC TCI TCC   OTA   acT cTG ATO GCC TCC TCT GOG TaT GTc cTc CAG OC G AG CTC TCC CCC TCA 
CCC CTC CC?
OAA 0A TG0 TCT TC? CAT CTO GAC ACC CT? 0G0 AC AAA TCC TAG TIC 1195 322 Amino acid residues are numbered on left; nucleotide positions are numbered on right. Positions of peptides that match predicted amino acids are shown by solid single lines. The two potential carbohydrate-binding sites to asparagine residues are shown by arrows. The third glycosylation site, the asparagine at position 37, is unlikely to occur because it is followed by aspartic acid (14) . Double underlining at the 5' end indicates the sequence used to primer-extend the 5' end; double underlining at the 3' end is the consensus poly(A) addition sequence. The CNBr peptide (Pe-1) sequenced with the o-phthalal- (Fig. 1B) . From the sequence WFIFWWPH of peptide Pe-5, the oligonucleotide TGGTTTATTTTCTGGTGGCCTCAT was chemically synthesized, 32p labeled at the 5' end with T4 polynucleotide kinase (New England Biolabs), and used as a probe to screen a human bone marrow cDNA library (see below).
Human mRNA and DNA Isolation. Poly(A)+ RNA was isolated as explained (11) and by using the Invitrogen isolation kit. mRNAs from Caucasian adult liver, spleen, kidney, brain, and fetal liver, as well as erythroleukemia cells K-562, were obtained from Clontech. DNA was obtained from peripheral blood leukocytes of the four Duffy phenotypes by a slight modification of a published procedure (12) .
RNA-Blot Analysis (Northern). Poly(A)+ RNAs were run on formaldehyde/agarose gel and transferred onto Hybond-N+ nylon membranes (Amersham). They were hybridized in QuickHyb (Stratagene) and washed according to the manufacturer's instructions.
DNA-Blot Analysis (Southern). All restriction enzyme digestions were done according to the conditions suggested by the supplier (New England Biolabs). Digested DNA was size-fractionated on 0.8% agarose gel and blotted as described for Northern analysis. Hybridization in QuickHyb solution was carried out at 68°C for 1 hr according to the manufacturer's instructions.
Construction and Screening of a cDNA Human Bone Marrow Library. A mixture of mRNA of several Fy(a-b+) individuals, the BRL Superscript Choice system, and oligo(dT) as a primer was used to prepare cDNA. The cDNA was ligated into AZAP II vector and packaged with Gigapack Gold (Stratagene) extract. About 1.9 x 106 unamplified cDNA clones were screened with the 32P-labeled probe described above. cDNA inserts in pBluescript were isolated by the plasmid-rescue method according to manufacturer's protocol. Both DNA strands were sequenced by using vector primers and by primers designed from the sequenced regions of the transcript.
Primer Extension. A 32P-labeled 24-mer antisense primer from nt 57-80 of the coding strand (Fig. 1B) was extended on Fy(a-b+) mRNA using a preamplification kit (BRL), and the products were separated on a 6% sequencing gel. The M13 sequence ladder was used to determine sizes of products.
RESULTS AND DISCUSSION
Partial Amino Acid Sequence of gpD Protein. In this study the gpD protein was purified from Fy(a-b+) erythrocytes. The N terminal of this highly hydrophobic protein was blocked. The obstacles to obtain internal sequences were its insolubility at neutral pH without detergents and its tendency to aggregate. After trial and error, the protein was digested with CNBr or pepsin, and three approaches were performed for amino acid sequencing. (i) The unfractionated CNBr peptide mixture was sequenced by blocking with the ophthalaldehyde reagent those peptides that lacked a proline in the earliest cycles of sequencing; the procedure yielded Pe-1 peptide of 16 residues (see legend for Fig. 1B). (ii) A fragment of the CNBr cleavage mixture (of =4 kDa) that resolved well on SDS/PAGE was sequenced and produced Pe-5 peptide of 23 residues. (iii) Four short pepsin fragments that eluted as single peaks from a reverse-phase HPLC column were sequenced and yielded Pe-2 and Pe-3 of five residues each, Pe-4 of three residues, and Pe-6 of nine residues (pepsin digestions at 100: 1 ratio and 4°C for 30 or 60 min did not generate larger peptides).
RNA Amplification by PCR. Pe-5 peptide was the most promising for generating a probe for the selection of gpD protein clones. Pe-2, Pe-3, Pe-4, and Pe-6 peptides were too short for PCR amplification, whereas the Pe-1 peptide was larger, but it had three ill-defined residues (see legend for Fig.  1B) (Fig. 1B) . A GenBank sequence search (release 77) at the National Center for Biotechnology Information using the BLAST network service yielded a significant protein sequence homology to human and rabbit interleukin-8 receptors and quasi-total nucleotide sequence homology with a human hippocampus cDNA clone HHCMF86 (see below). Verification of the 5' end of clone Fyb8l was done by primer extension. The extended product of an antisense primer (from position 57 to 80, Fig. 1B ) yielded a sequence of 80 nt that matched exactly with the predicted size at the 5' end of the Fyb8l clone (data not shown). At positions 176-178, the initiation codon is not embedded within a sequence context most frequently associated with mammalian translation initiation (13) . We assumed, however, that it is the true initiation codon for the following reasons: (i) it is the only ATG codon at the 5' end; and (ii) from the first methionine residue, the polypeptide encoded by the combined clones has the same molecular mass as that of deglycosylated gpD protein (6) . At the 3' end, clone Fyb7l-81 included the consensus poly(A) addition signal AATTAAA (Fig. 1B) .
Both clones had a perfect nucleotide sequence match, except at the 5' end, where several base substitutions yielded six different amino acid predictions. These discrepancies were not a sequencing error because both DNA strands were sequenced several times. They were a consequence of protein heterogeneity because the cDNA library was constructed from mRNA of several Fy(a-b+) individuals.
To establish that clone Fyb7l-81 had a coding sequence specific to gpD protein, we compared the translated sequence with the partial amino acid sequence data obtained from the six peptides described in the legend of Fig. 1B . Portions ofthe predicted amino acid sequence matched with Pe-1 peptide sequenced by the o-phthalaldehyde reagent, with four peptides isolated by reverse-phase HPLC (Pe-2, Pe-3, Pe-4, and Pe-6 peptides), and with the Pe-5 peptide isolated by SDS/ PAGE. However, two of a total of 62 residues did not match. Thus, the residues at position 92 and 327 were tryptophan by codon sequence analysis, but they were isoleucine and arginine, respectively, by amino acid sequence determination.
Because tryptophan is a very unstable residue, the discrepancies may be a technical problem in amino acid sequence analysis. On the other hand, they may be due to the heterogeneity of gpD protein.
Additional evidence that clone Fyb7l-81 encoded gpD protein was provided by RNA blot and ELISA analysis. Probe Fyb8l did not detect any bone marrow mRNA in Duffy-negative individuals, but it detected an =1.27-kb transcript representing the full-length of gpD mRNA in Duffypositive individuals (see Fig. 3A ). Anti-Fy6 antibody reacted with a 35-mer synthetic peptide (residues 9-44, see Fig. 1B) , predicted by the Fyb7l-81 clone (data not shown). The absence of gpD protein-specific mRNA in Fy(a-b-) (14) . This result agrees with previous investigations that N-glycosidase F digestion increases gpD protein mobility on SDS/PAGE and with the chemical detection of N-acetylglucosamine (6, 15, 16) .
Predictions of transmembrane helices locations from sequence data using the hydropathy map of Engelman et al. (17) and a scanning window of 20 residues show that the bulk of the protein is embedded in the membrane (Fig. 2) . Nine transmembrane a-helices, a hydrophilic domain of 66 residues at the N terminus, a hydrophilic domain of 25 residues at the C terminus, and short protruding hydrophilic connecting segments were predicted. The pair of helices, D and E, is so closely spaced that the pair may be arranged as coupled -& Hydropathy values for a membrane-span of 20 residues were determined using the FOAMPC program as, described by Engelman et al. (17) . The predicted a-helices were assigned alphabetical labels from A to I. (Lower) Proposed model for membrane orientation ofgpD was based on the predictions of the hydropathy profile and on the exocellular location of the N terminus determined from the charge-difference rule, the two potential glycosylation sites, and anti-Fy6 reactivity. anti-parallel helices. A schematic illustration topology is shown in Fig. 2 . The charge-difference rule proposed by l (18) predicts that the N terminus is on the exo the C terminus of the protein is on the cytopla membrane. The N-terminal prediction is v finding of the two potential N-glycosylation terminus. Moreover, the reaction of anti-Fy6 peptide deduced from this domain establishe location experimentally because the antibod) rocytes. The signal-anchor sequence (19, 20 insertion probably lies in the first transmembr follows the N-terminal domain. From there o deeply buried in the membrane and exits at re cytoplasmic side of the membrane (Fig. 2) .
predictions of helices, hydrophilic connectinj the location of the C-terminal fragment shou ated by direct biochemical and immunochen Duffy gpD protein is deeply buried in the the membrane-associated fragment of band 3 blood group Rh polypeptide (22, 23) , bacteric and lipophilin (25) . The significant homology express the blood group determinants. membrane like As indicated in Fig. 4 , a 1.27-kb mRNA species was found (21), the human in adult spleen and kidney, fetal liver but not in adult liver, )rhodopsin (24) , and K-562 erythroleukemia cells. Hybridization with the ( of gpD protein ,B-globin probe showed a strong signal in bone marrow and (26, 27 (Fig. 3A) . The untranslated sequences. Perhaps the brain mRNA codes for the absence of a larger protein that has extensive homology with gpD Anti-gpD antiprotein. The homologies of these mRNA species with gpDbrane protein of specific mRNA remain to be demonstrated by sequence Duffy-negative analysis; however, the findings strongly indicate that gpD protein or a similar protein is produced in kidney, nonhemopoietic spleen cells, and probably in brain. In summary, we have isolated four cDNA clones that encode gpD protein, the major subunit of the Duffy blood group antigenic system. It is a highly hydrophobic intramemw _ brane glycoprotein with nine putative transmembrane a-helices. The cognate gene is present in Duffy-positive and -negative individuals, but the bone marrow ofDuffy-negative individuals does not synthesize gpD-specific mRNA. In adult kidney, spleen, and fetal liver, the mRNA has the same size as gpD mRNA; however, in brain the mRNA is much larger. 4 . RNA blot analysis of poly(A)+ RNA from human tissues probed with the insert of Fyb8l clone. Lanes 1, 3, 5, and 7 contained 2 pg of Fy(a-b+) bone marrow, fetal liver, adult spleen, and erythroleukemia (K-562) mRNAs, respectively. Lanes 2, 4, and 6 contained 7 pg of total brain, adult liver, and adult kidney mRNA, respectively. RNAs were resolved on a 1.5% denaturing agarose gel and autoradiographed for 5 days at -80°C.
